Global Cell and Gene Therapy CDMO Supply, Demand and Key Producers, 2023-2029

Global Cell and Gene Therapy CDMO Supply, Demand and Key Producers, 2023-2029

The global Cell and Gene Therapy CDMO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Cell and Gene Therapy CDMO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy CDMO that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Cell and Gene Therapy CDMO total market, 2018-2029, (USD Million)

Global Cell and Gene Therapy CDMO total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Cell and Gene Therapy CDMO total market, key domestic companies and share, (USD Million)

Global Cell and Gene Therapy CDMO revenue by player and market share 2018-2023, (USD Million)

Global Cell and Gene Therapy CDMO total market by Type, CAGR, 2018-2029, (USD Million)

Global Cell and Gene Therapy CDMO total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Cell and Gene Therapy CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Charles River Laboratories, Cytiva, Catalent Biologics, FUJIFILM Diosynth Biotechnologies, BioCentriq, RoslinCT, Thermo Scientific and Mesoblast, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy CDMO market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cell and Gene Therapy CDMO Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Cell and Gene Therapy CDMO Market, Segmentation by Type
Clinical Trial Material CDMOs
Development and Manufacturing CDMOs
Other

Global Cell and Gene Therapy CDMO Market, Segmentation by Application
Pharmaceutical Company
Biotechnology Company
Other

Companies Profiled:
Lonza
Charles River Laboratories
Cytiva
Catalent Biologics
FUJIFILM Diosynth Biotechnologies
BioCentriq
RoslinCT
Thermo Scientific
Mesoblast
Cellularity
Bluebird Bio
Editas Medicine
Andelyn Biosciences
Wuxi Advanced Therapies
AGC Biologics
Pfizer CentreOne
Almac Group
PCI Pharma Services

Key Questions Answered

1. How big is the global Cell and Gene Therapy CDMO market?

2. What is the demand of the global Cell and Gene Therapy CDMO market?

3. What is the year over year growth of the global Cell and Gene Therapy CDMO market?

4. What is the total value of the global Cell and Gene Therapy CDMO market?

5. Who are the major players in the global Cell and Gene Therapy CDMO market?